Top stories in cardiology from the National Lipid Association Scientific Sessions

Among the top stories in cardiology is meeting news from the National Lipid Association Scientific Sessions, which took place from April 26 through April 29 in Las Vegas. Nonstatin therapies reduce the risk for CVD in patients who require additional LDL lowering, according to one presentation. Other presentations showed that plant-based diets can reduce risk for CV-related events and mortality, children with familial hypercholesterolemia could experience reduced CV risk from early initiation of statin therapy, and numerous medications could reduce LDL and the risk for CVD in patients with cardiometabolic conditions.

Nonstatin therapies aid in additional LDL lowering

Nonstatin therapies such as ezetimibe and PCSK9 inhibitors reduce the risk for CVD in patients who require additional LDL lowering, according to a presentation at the National Lipid Association Scientific Sessions. Read More.

Plant-based diets reduce CV risk

Plant-based diets can reduce risk for CV-related events and mortality as effectively as pharmacotherapies, according to a presentation at the National Lipid Association Scientific Sessions. Read More.

Children with FH may benefit from early statin initiation

Early initiation of statin therapy may reduce CV risk in children with familial hypercholesterolemia, according to a presentation at National Lipid Association Scientific Sessions. Read More.

Different targets available for preventing CVD in cardiometabolic conditions

Data suggest that numerous medications have the ability to reduce LDL and the risk for CVD in patients with cardiometabolic conditions, although deciding which treatment is best suited for a patient may need to be done on a case-by-case basis, according to a presentation at National Lipid Association Scientific Sessions. Read More.

Faster walking speed lowers CV hospitalization risk in hypertension, CVD

Patients with hypertension and CVD who walk at a faster pace had lower rates of hospitalization vs. those walking at a slower pace, according to results published in the European Journal of Preventive Cardiology. Read More.